Procurement of Pharmaceutical Products

Through this Request For Proposals (“RFP”), the Global Fund to Fight AIDS, Tuberculosis and Malaria (the “Global Fund”) invites all potential bidders to submit proposals to supply World Health Organization (WHO) recommended Antimalarial and Antiretroviral Medicines during 2023 to 2025 to, or for the benefit of, recipients of Global Fund financing or other entities, as fully described in this RFP through framework agreements with the Global Fund.

The Global Fund will offer two types of framework agreements that are differentiated by the type of engagement and level of allocation and commitment:

Strategic Partnership Agreement: This type of agreement is expected to be appropriate for suppliers that can demonstrate the ability to supply products throughout their lifecycle and who have the commitment and available resources to work collaboratively in a structured fashion to create value. This category of agreement is expected to include allocated and /or committed volumes on products for which the Global Fund has demand visibility.

Purchase Order Agreement: This category of agreement will establish the framework of the relationship under which selected products will be supplied through individual Purchase Orders as needed, under certain conditions such as when a Strategic Partnership Agreement Supplier is unable to meet the demand request, including when there are intellectual property restrictions. This category of agreement will not include allocated or committed volumes.

The preference for the type of framework agreement can be selected by the bidder at the time of submission.

Download RFP in English